Psychedelics One dose of psilocybin can alleviate depression for 5 years, U.S. researchers find The finding came from follow up with participants from a 2020 magic mushroom study Rowan DunneJune 27, 2025
Psychedelics Colorado governor pardons citizens convicted of psilocybin possession The state has been taking the reins when it comes to psychedelic reformation Rowan DunneJune 20, 2025
Psychedelics New Zealand gives green light to prescribe magic mushrooms for depression The nation has now joined Australia in this regard Rowan DunneJune 19, 2025
Psychedelics Mindstate Design Labs uses AI to provide customized psychedelic experiences The biotech startup secured FDA approval for Phase I studies on its lead candidate in September Rowan DunneJune 17, 2025
News Home cannabis cultivation and psilocybin therapy to be legal in Czechia next year The nation's Senate still needs to approve the laws, but opposition is not anticipated Rowan DunneJune 11, 2025
Psychedelics University student discovers novel psychoactive fungus on flower She has found what Alberta Hofmann sought but was never able to find Rowan DunneJune 6, 2025
Psychedelics Beckley Psytech & atai Life Sciences to combine expertise in pivotal merger The important news follows the passing of Beckley co-founder Amanda Feilding Rowan DunneJune 2, 2025
Psychedelics Gilgamesh’s psychedelic drug demonstrates exceptional efficacy for treating depression GM-2505 is a compound with faster onset and shorter duration than psilocybin Rowan DunneMay 30, 2025
Psychedelics Texas makes its mark on psychedelics sector with US$50M in ibogaine research funding It's being called the largest publicly-funded psychedelic research initiative in history Rowan DunneMay 22, 2025
Psychedelics Canadian professors launch book on ‘Psychedelic Capitalism’ in Manitoba this week It provides a critical analysis of the current industry climate Rowan DunneMay 13, 2025